Literature DB >> 2073588

Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat.

G E Jaskiw1, F Karoum, W J Freed, I Phillips, J E Kleinman, D R Weinberger.   

Abstract

To determine the influence of intrinsic medial prefrontal cortex (MPFC) neurons on regional brain catecholamine turnover, dopamine (DA) and its metabolites were assayed in several brain areas 14 and 28 days after bilateral ibotenic acid (IA) lesions of the MPFC in the rat. The locomotor response to D-amphetamine was also assessed. On the 14th postoperative day levels of DA, homovanillic acid concentrations and 3,4-dihydroxyphenylacetic acid were elevated in the anterior striatum of IA-lesioned animals. Spontaneous and amphetamine-induced locomotion were also increased. These changes disappeared by the 28th postoperative day. It is concluded that destruction of the efferents of the MPFC induces transient increases in DA turnover within the medial striatum and transiently increases spontaneous and amphetamine-induced locomotion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2073588     DOI: 10.1016/0006-8993(90)90138-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

Review 1.  Animal models of schizophrenia: a critical review.

Authors:  E R Marcotte; D M Pearson; L K Srivastava
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

2.  Glutaminergic signaling in the caudate nucleus is required for behavioral sensitization to methylphenidate.

Authors:  Nicholas King; Samuel Floren; Natasha Kharas; Ming Thomas; Nachum Dafny
Journal:  Pharmacol Biochem Behav       Date:  2019-06-19       Impact factor: 3.533

3.  Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex.

Authors:  G Flores; G K Wood; J J Liang; R Quirion; L K Srivastava
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

4.  Omega-3 fatty acid deficiency impairs frontostriatal recruitment following repeated amphetamine treatment in rats: A 7 Tesla in vivo phMRI study.

Authors:  Robert K McNamara; Jennifer D Schurdak; Ruth H Asch; Diana M Lindquist
Journal:  Nutr Neurosci       Date:  2017-12-29       Impact factor: 4.994

5.  Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats.

Authors:  N R Swerdlow; B K Lipska; D R Weinberger; D L Braff; G E Jaskiw; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

6.  Adolescent social defeat alters neural, endocrine and behavioral responses to amphetamine in adult male rats.

Authors:  Andrew R Burke; Kenneth J Renner; Gina L Forster; Michael J Watt
Journal:  Brain Res       Date:  2010-07-23       Impact factor: 3.252

7.  Effects of adolescent social defeat on adult amphetamine-induced locomotion and corticoaccumbal dopamine release in male rats.

Authors:  Andrew R Burke; Gina L Forster; Andrew M Novick; Christina L Roberts; Michael J Watt
Journal:  Neuropharmacology       Date:  2012-12-06       Impact factor: 5.250

Review 8.  Executive function, neural circuitry, and genetic mechanisms in schizophrenia.

Authors:  Daniel Paul Eisenberg; Karen Faith Berman
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  Presynaptic regulation of extracellular dopamine levels in the medial prefrontal cortex and striatum during tyrosine depletion.

Authors:  Zachary Brodnik; Manda Double; George E Jaskiw
Journal:  Psychopharmacology (Berl)       Date:  2013-02-01       Impact factor: 4.530

10.  Medial prefrontal cortex lesions impair decision-making on a rodent gambling task: reversal by D1 receptor antagonist administration.

Authors:  Tracie A Paine; Samuel K Asinof; Geoffrey W Diehl; Anna Frackman; Joseph Leffler
Journal:  Behav Brain Res       Date:  2013-01-24       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.